Obodence
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Obodence, covering 2026-01-06 to 2026-08-04. Get the full timeline:
Most recent: EMA Authorised: Obodence (denosumab) — Samsung Bioepis NL B.V.
2 regulatory and trial events tracked for Obodence, covering 2026-01-06 to 2026-08-04. Get the full timeline:
Most recent: EMA Authorised: Obodence (denosumab) — Samsung Bioepis NL B.V.